Abivax S.A.

AAVXF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$101-$95-$82-$96
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$1
Stock-Based Comp.$11$9$11$8
Change in WC$2-$3$4-$8
Other Non-Cash$20$19-$20$26
Operating Cash Flow-$67-$69-$85-$70
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$0-$9
Inv. Sales/Matur.$0$0$0$1
Other Inv. Act.$1$2$14-$6
Investing Cash Flow$1$2$13-$6
Financing Activities
Debt Repay.-$13-$5$43$0
Stock Issued$0$0$0$202
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4-$7-$2$219
Financing Cash Flow-$17-$12$40$219
Forex Effect-$2$1$2-$5
Net Chg. in Cash$61-$78$222$138
Supplemental Information
Beg. Cash$0$222$0$114
End Cash$61$144$222$252
Free Cash Flow-$67-$69-$85-$70
Abivax S.A. (AAVXF) Financial Statements & Key Stats | AlphaPilot